{"count": 201, "results": [{"_id": "34334083", "pmid": 34334083, "pmcid": "PMC8806643", "title": "Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication", "journal": "Bioengineered", "authors": ["Yang L", "Yang J", "Liang X", "Huang W", "Zhang X", "Li R"], "date": "2021-12-01T00:00:00Z", "doi": "10.1080/21655979.2021.1954581", "meta_date_publication": "2021 Dec", "meta_volume": "12", "meta_issue": "1", "meta_pages": "4757-4767", "score": 50268.6, "text_hl": "Uncovering antiobesity-related @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@ targets and mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an antidiabetic medication", "citations": {"NLM": "Yang L, Yang J, Liang X, Huang W, Zhang X, Li R. Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication Bioengineered. 2021 Dec;12(1):4757-4767. PMID: 34334083", "BibTeX": "@article{34334083, title={Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication}, author={Yang L and Yang J and Liang X and Huang W and Zhang X and Li R}, journal={Bioengineered}, volume={12}, number={1}, pages={4757-4767}}"}}, {"_id": "36790596", "pmid": 36790596, "pmcid": "PMC9930700", "title": "Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects", "journal": "Am J Cardiovasc Drugs", "authors": ["Freeman MW", "Bond M", "Murphy B", "Hui J", "Isaacsohn J"], "date": "2023-02-15T00:00:00Z", "doi": "10.1007/s40256-023-00572-x", "meta_date_publication": "2023 Feb 15", "meta_volume": "", "meta_issue": "", "meta_pages": "1-10", "score": 50267.133, "text_hl": "Due to the high comorbidity of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@, co-administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with anti-@<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive drugs@@@ is likely. ", "citations": {"NLM": "Freeman MW, Bond M, Murphy B, Hui J, Isaacsohn J. Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects Am J Cardiovasc Drugs. 2023 Feb 15;():1-10. PMID: 36790596", "BibTeX": "@article{36790596, title={Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects}, author={Freeman MW and Bond M and Murphy B and Hui J and Isaacsohn J}, journal={Am J Cardiovasc Drugs}, pages={1-10}}"}}, {"_id": "34202343", "pmid": 34202343, "pmcid": "PMC8268471", "title": "Prevention of Hypertensive Disorders of Pregnancy:Is There a Place for Metformin?", "journal": "J Clin Med", "authors": ["Poniedziałek-Czajkowska E", "Mierzyński R", "Dłuski D", "Leszczyńska-Gorzelak B"], "date": "2021-06-25T00:00:00Z", "doi": "10.3390/jcm10132805", "meta_date_publication": "2021 Jun 25", "meta_volume": "10", "meta_issue": "13", "meta_pages": "", "score": 50262.926, "text_hl": "The aim of this study is to present the possibility of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the prevention of @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive disorders of@@@ pregnancy with respect to its impact on the pathogenic elements of development", "citations": {"NLM": "Poniedziałek-Czajkowska E, Mierzyński R, Dłuski D, Leszczyńska-Gorzelak B. Prevention of Hypertensive Disorders of Pregnancy:Is There a Place for Metformin? J Clin Med. 2021 Jun 25;10(13):. PMID: 34202343", "BibTeX": "@article{34202343, title={Prevention of Hypertensive Disorders of Pregnancy:Is There a Place for Metformin?}, author={Poniedziałek-Czajkowska E and Mierzyński R and Dłuski D and Leszczyńska-Gorzelak B}, journal={J Clin Med}, volume={10}, number={13}}"}}, {"_id": "37055870", "pmid": 37055870, "pmcid": "PMC10103437", "title": "Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats", "journal": "Lab Anim Res", "authors": ["Moke EG", "Omogbai EKI", "Osagie-Eweka SE", "Uchendu AP", "Obayuwana OM", "Okoro-Akpandu E", "Ben-Azu B"], "date": "2023-04-14T00:00:00Z", "doi": "10.1186/s42826-023-00159-2", "meta_date_publication": "2023 Apr 14", "meta_volume": "39", "meta_issue": "1", "meta_pages": "7", "score": 50262.74, "text_hl": "Antihypertensive and antihyperglycemic effects of combinations of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and/or @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ in @CHEMICAL_Desoxycorticosterone_Acetate @CHEMICAL_MESH:D064791 @@@desoxycorticosterone acetate@@@ and @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-induced @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive diabetic@@@ rats", "citations": {"NLM": "Moke EG, Omogbai EKI, Osagie-Eweka SE, Uchendu AP, Obayuwana OM, Okoro-Akpandu E, Ben-Azu B. Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats Lab Anim Res. 2023 Apr 14;39(1):7. PMID: 37055870", "BibTeX": "@article{37055870, title={Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats}, author={Moke EG and Omogbai EKI and Osagie-Eweka SE and Uchendu AP and Obayuwana OM and Okoro-Akpandu E and Ben-Azu B}, journal={Lab Anim Res}, volume={39}, number={1}, pages={7}}"}}, {"_id": "36067082", "pmid": 36067082, "pmcid": "PMC9581086", "title": "Predictors of rapid progression of estimated glomerular filtration rate among persons living with diabetes and/or hypertension in Ghana: Findings from a multicentre study", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Ofori E", "Gyan KF", "Gyabaah S", "Nguah SB", "Sarfo FS"], "date": "2022-10-01T00:00:00Z", "doi": "10.1111/jch.14568", "meta_date_publication": "2022 Oct", "meta_volume": "24", "meta_issue": "10", "meta_pages": "1358-1369", "score": 50260.863, "text_hl": "The trajectory of eGFR is affected by both modifiable and non-modifiable risk factors including age, coverage of health insurance, history of smoking, and the use of angiotensin receptor blockade (ARB) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in individuals with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ and/or @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Ofori E, Gyan KF, Gyabaah S, Nguah SB, Sarfo FS. Predictors of rapid progression of estimated glomerular filtration rate among persons living with diabetes and/or hypertension in Ghana: Findings from a multicentre study J Clin Hypertens (Greenwich). 2022 Oct;24(10):1358-1369. PMID: 36067082", "BibTeX": "@article{36067082, title={Predictors of rapid progression of estimated glomerular filtration rate among persons living with diabetes and/or hypertension in Ghana: Findings from a multicentre study}, author={Ofori E and Gyan KF and Gyabaah S and Nguah SB and Sarfo FS}, journal={J Clin Hypertens (Greenwich)}, volume={24}, number={10}, pages={1358-1369}}"}}, {"_id": "33133865", "pmid": 33133865, "pmcid": "PMC7594657", "title": "Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence", "journal": "Cureus", "authors": ["Sahay RK", "Mittal V", "Gopal GR", "Kota S", "Goyal G", "Abhyankar M", "Revenkar S"], "date": "2020-09-28T00:00:00Z", "doi": "10.7759/cureus.10700", "meta_date_publication": "2020 Sep 28", "meta_volume": "12", "meta_issue": "9", "meta_pages": "e10700", "score": 50259.285, "text_hl": "Studies report the CV protection of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, as it reduces the risk factors of @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CV diseases@@@, including @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@, @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@, and @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@; thus, lowering the incidence of @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CVD@@@. ", "citations": {"NLM": "Sahay RK, Mittal V, Gopal GR, Kota S, Goyal G, Abhyankar M, Revenkar S. Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence Cureus. 2020 Sep 28;12(9):e10700. PMID: 33133865", "BibTeX": "@article{33133865, title={Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence}, author={Sahay RK and Mittal V and Gopal GR and Kota S and Goyal G and Abhyankar M and Revenkar S}, journal={Cureus}, volume={12}, number={9}, pages={e10700}}"}}, {"_id": "31721026", "pmid": 31721026, "pmcid": "PMC7266803", "title": "Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial", "journal": "Am J Cardiovasc Drugs", "authors": ["Ono K", "Wada H", "Satoh-Asahara N", "Inoue H", "Uehara K", "Funada J", "Ogo A", "Horie T", "Fujita M", "Shimatsu A", "Hasegawa K", "ABLE-MET Investigators"], "date": "2020-06-01T00:00:00Z", "doi": "10.1007/s40256-019-00381-1", "meta_date_publication": "2020 Jun", "meta_volume": "20", "meta_issue": "3", "meta_pages": "283-293", "score": 50258.816, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Left Ventricular Size and Function in @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@Hypertensive@@@ @SPECIES_9606 @@@Patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes Mellitus@@@: Results of a Randomized, Controlled, Multicenter, Phase IV Trial", "citations": {"NLM": "Ono K, Wada H, Satoh-Asahara N, Inoue H, Uehara K, Funada J, Ogo A, Horie T, Fujita M, Shimatsu A, Hasegawa K, ABLE-MET Investigators. Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial Am J Cardiovasc Drugs. 2020 Jun;20(3):283-293. PMID: 31721026", "BibTeX": "@article{31721026, title={Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial}, author={Ono K and Wada H and Satoh-Asahara N and Inoue H and Uehara K and Funada J and Ogo A and Horie T and Fujita M and Shimatsu A and Hasegawa K and ABLE-MET Investigators}, journal={Am J Cardiovasc Drugs}, volume={20}, number={3}, pages={283-293}}"}}, {"_id": "37085892", "pmid": 37085892, "pmcid": "PMC10122301", "title": "Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study", "journal": "Cardiovasc Diabetol", "authors": ["Mone P", "Martinelli G", "Lucariello A", "Leo AL", "Marro A", "De Gennaro S", "Marzocco S", "Moriello D", "Frullone S", "Cobellis L", "Santulli G"], "date": "2023-04-21T00:00:00Z", "doi": "10.1186/s12933-023-01817-4", "meta_date_publication": "2023 Apr 21", "meta_volume": "22", "meta_issue": "1", "meta_pages": "94", "score": 50258.273, "text_hl": "We included a control group of frail older males with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@ treated with extended-release @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and a control group of frail older @SPECIES_9606 @@@women@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@ treated with regular @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Mone P, Martinelli G, Lucariello A, Leo AL, Marro A, De Gennaro S, Marzocco S, Moriello D, Frullone S, Cobellis L, Santulli G. Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study Cardiovasc Diabetol. 2023 Apr 21;22(1):94. PMID: 37085892", "BibTeX": "@article{37085892, title={Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study}, author={Mone P and Martinelli G and Lucariello A and Leo AL and Marro A and De Gennaro S and Marzocco S and Moriello D and Frullone S and Cobellis L and Santulli G}, journal={Cardiovasc Diabetol}, volume={22}, number={1}, pages={94}}"}}, {"_id": "37090575", "pmid": 37090575, "pmcid": "PMC10120765", "title": "Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data", "journal": "Res Sq", "authors": ["Tao C", "Lundin S", "Hu X", "Feng J", "Lundin K", "Chen Y"], "date": "2023-04-13T00:00:00Z", "doi": "10.21203/rs.3.rs-2629005/v1", "meta_date_publication": "2023 Apr 13", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.926, "text_hl": "Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ with Reduced @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@ and Related @DISEASE_Dementia @DISEASE_MESH:D003704 @@@Dementias@@@ Risk among @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@Hypertensive@@@ @SPECIES_9606 @@@Patients@@@ with Mild @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@Cognitive Impairment@@@ using High Volume Claims Data", "citations": {"NLM": "Tao C, Lundin S, Hu X, Feng J, Lundin K, Chen Y. Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data Res Sq. 2023 Apr 13;():. PMID: 37090575", "BibTeX": "@article{37090575, title={Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data}, author={Tao C and Lundin S and Hu X and Feng J and Lundin K and Chen Y}, journal={Res Sq}}"}}, {"_id": "40852348", "pmid": 40852348, "title": "Role of Metformin in Preeclampsia: A Systematic Review.", "journal": "J Obstet Gynaecol India", "authors": ["Anuja M", "Arthy M", "Jha N", "Ashok MV", "Jha AK", "Sivaranjani P"], "date": "2025-08-01T00:00:00Z", "doi": "10.1007/s13224-025-02194-6", "meta_date_publication": "2025 Aug", "meta_volume": "75", "meta_issue": "4", "meta_pages": "282-289", "score": 50254.594, "text_hl": "When compared to other drugs, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is more likely to avoid pregnancy-related @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension disorders@@@. ", "citations": {"NLM": "Anuja M, Arthy M, Jha N, Ashok MV, Jha AK, Sivaranjani P. Role of Metformin in Preeclampsia: A Systematic Review. J Obstet Gynaecol India. 2025 Aug;75(4):282-289. PMID: 40852348", "BibTeX": "@article{40852348, title={Role of Metformin in Preeclampsia: A Systematic Review.}, author={Anuja M and Arthy M and Jha N and Ashok MV and Jha AK and Sivaranjani P}, journal={J Obstet Gynaecol India}, volume={75}, number={4}, pages={282-289}}"}}]}